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1. introduction 
Chromosomal protein A24 was first described 
by its electrophoretic mobility on two-dimensional 
polyacrylamide gels [I]. It was identified as a con- 
jugated chromatin protein composed of histone 2A 
[2] and a ubiquitin moiety [3-51 which was linked 
by an isopeptide bond from a carboxyl terminal 
glycylglycine to the e-NH2 of lysine 119 of histone 
2A [6-81. Protein A24 has been found to be an inte- 
gral component of a subset of chromatin nucleo- 
some core particles [9-l I]. 
Levels of protein A24 markedly decreased during 
nucleolar hypertrophy [12-l 41 and in some active 
chromatin fractions where free ubiquitin was found 
[15-l 71. Cleavage of the ubiquitin-histone 2A bond 
may be involved in some transcription systems [IS]. 
Moreover, in chromatin the ubiquitin portion of pro- 
tein A24 turns over throughout interphase [18,19]. 
Recently, an enzyme, protein A24 lyase, was described 
which cleaved both free and nucleosomal protein A24 
and analysis of the products by gel electrophoresis 
implied that the enzyme catalyzed a deconjugation 
[20]. This report is the carboxyl-terminal sequence 
analysis of the ubiquitin released from purified pro- 
tein A24 by the lyase. Inasmuch as the lyase released 
ubiquitin with an intact glycylglycine terminus. The 
results indicate that the site of cleavage in protein 
A24 is at the isopeptide linkage between the carboxyl 
terminal dycine residue 76 of ubiquitin and the 
e-amino group of lysine residue 119 of histone 2A. 
2. Experimental 
2.1. Solubilization of protein A24 lyase from rat liver 
nuclei 
All operations were performed at 0-4°C. Sucrose- 
Mg2+ liver nuclei [21] from 3 Holtzman rats were 
suspended in 18.5 ml 0.05 M Tris (‘pH 7.9)/S% 
glycerol/5 mM Mg acetate/O.1 mM Naa EDTA/l mM 
dithiothreitol/l mM PMSF (TGMEDP-8%). A 4 M 
ammonium sulfate solution (1.5 ml) was added fol- 
lowed by stirring for 15 min and sonication to low 
viscosity. After centrifugation at 100 000 X g for 
60 min, ammonium sulfate was reduced to 0.1 M by 
addition of 40 ml TGMEDP-8%. After stirring for 
1.5 mm and centrifugation as above, addition of 
ammonium sulfate to 80% saturation yielded a pre- 
cipitate which was collected by centrifugation at 
10 000 X g for 15 min. The pellet was suspended in 
0.05 M Tris (PH 7.9)/25% glycerol/S mM Mg acetate/ 
0.1 mM EDTA/O.S mM dithiothreitol/OS mM PMSF 
in 0.1 M NaCl followed by dialysis twice against 1 liter 
of the same buffer. After centrifugation at 10 000 X g 
for 10 min, the supernatant was used as protein A24 
lyase [20]. 
2.2. Polyacrylamide-SDSgel electrophoresis 
As described in [20] samples were analyzed by 
one-dimensional 12% acrylamide/O.l% SDS/O.1 M 
sodium phosphate (pH 7.1)/6 M urea gel electropho- 
resis. The gels were stained in 0.22% Coomassie 
brilliant blue-R/30% methanol/lo% acetic acid and 
destained in 33% methanol/l 0% acetic acid. 
2.3. Isolation of ubiquitin from rat erythrocytes 
Isolation of ubiquitin was by a modification of the 
procedures in [22,23]. Blood from 6 rats was placed 
in 200 ml ice-cold phosphate-buffered saline (0.15 M 
NaCl/O.Ol M sodium phosphate (pH 7.4)/l mM PMSF) 
followed by filtration through 4 layers of cheesecloth 
and centrifugation at 1700 X g for 10 min. The pellet 
was homogenized in 100 ml 0.05 M Tris (JJH 7.9)/l mM 
dithiothreitol/l mM PMSF/O.l mM leupeptin and 
centrifuged at 12 000 X g for 30 min. The super- 
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Fig.1. Polyacrylamide gel electrophoresis of ubiquitin. One- 
dimensional 12% SDS-polyacrylamide gel electrophoresis 
was uerformed as in section 2.: (A) rat liver histone markers; 
(B) dalf thymus ubiquitin marker (UB); (C) heat-stable pro- 
teins of rat erythrocytes; (D) purified red cell ubiquitin; 
(E) histone plus ubiquitin markers; (F) ubiquitin isolated 
from the protein A24 lyase reaction; (A-D and E,F) are 
taken from two separate runs. 
GLY-GLY 
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natant was heated to 90°C for 15 min, cooled on ice 
for 30 mm and centrifuged at 12 000 X g for 20 min. 
The supernatant was filtered through Whatman no. 1 
paper and brought to 100% of saturation with ammo- 
nium sulfate. The precipitate was dissolved in 0.05 M 
Tris (PH 7.9)/0.5 mM PMSF/O.S mM dithiothreitol, 
dialyzed against the same buffer at 4°C and centrifuged 
at 10 000 X g for 15 min. The supernatant was heat 
treated and centrifuged as above. The supernatant 
(fig.1 C) was passed at room temperature through a 
combined column consisting of a 4 ml layer of DEAE- 
Sephadex upon which was placed a 4 ml layer of 
phosphocellulose, and which was equilibrated with 
0.05 M Tris (pH 7.5)/l mM PMSF/l mM dithiothreitol. 
The flow-through fraction contained electropho- 
retically pure ubiquitin (fig. 1 D). 
J 
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Fig.2. Analysis of trypsin-treated ubiquitin. Isolated ubiquitin (15-20 ng protein) was trypsinized and applied to chromatography 
on a Beckman 121 MB amino acid analyzer as in section 2. Tracings of the elution profile were superimposed for comparison: (A) 
protein A24 lyase generated ubiquitin; (B) rat erythrocyte ubiquitin; (C) 3 nmol commercial glycylglycine (Sigma) applied 
directly to the amino acid analyzer; (A,B) measured on the 0.1 absorbance range; (C) on the 0.5 absorbance range. 
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2.4. Isolation of protein A24 lyase released ubiquitin 2.6. Carboxyl-terminal analysis of ubiquitin 
Purified protein A24 (1 mg) prepared as in [24] 
was incubated at 37°C for 2 h with 1 mg protein A24 
lyase in 1 ml 0.05 M Tris (pH 7.5)/ 1 mM PMSF/l mM 
dithiothreitol (TPD) followed by heating at 100°C 
for 5 min [20]. After centrifugation at 15 000 X g 
for 3 min, the supernatant was made 2% with trichlo- 
roacetic acid followed by centrifugation as above 
and dialysis against 1 liter of TPD. Chromatography 
through a combined phosphocellulose-DEAE- 
Sephadex column was as described above (fig.1 F). 
In addition, ubiquitin (10 pg) was digested with 
0.005 units carboxypeptidase A or 0.04 units car- 
boxypeptidase B and the digests subjected to amino 
acid analysis 14,251. Hydrazinolysis was performed 
on 40-50 pg ubiquitin as in [6,26]. 
3. Results 
2.5. Trypsin treatment of isolated ubiquitin 
Ubiquitin (15-30 yg protein) isolated from rat 
erythrocytes or released from protein A24 by the 
lyase was digested with 2 pg trypsin for 2 h at 37°C 
in 0.1 ml 0.1 MN-ethyl morpholine acetate (PH 7.5) 
followed by heating at 100°C for 5 min. The sample 
was lyophilized, dissolved in pH 2.2 sodium citrate 
(Beckman Instruments), and analyzed on a Beckman 
12 1 MB amino acid analyzer. 
Trypsin treatment of ubiquitin should cleave at 
arginine residue 74 to release any peptide on its 
C-terminal side because the remainder of the ubiquitin 
(residues l-74) is trypsin resistant [5,7]. When rat 
red-cell ubiquitin and the protein A24 lyase generated 
ubiquitin were trypsinized and amino acid analysis 
was done on the products, the peaks from both 
sources of ubiquitin (fig.2A,B) comigrated with com- 
mercial glycylglycine (fig.2C). 
il 
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Fig.3. Trypsin treatment of protein A24 lyase-released ubiquitin. The protein A24 lyase reaction was performed as in section 2, 
both in the absence and presence of 1 mg protein A24. The trichloroacetic acid step was omited from the ubiquitin isolation 
procedure and the tandem DEAE-Sephadex and phosphocellulose flow-through fractions were trypsin treated prior to analysis as 
in fig.2. Tracings of the analyzer profiles were superimposed for comparison: (A) protein A24 lyase reaction in the presence of 
protein A24; (B) without protein A24; (A,B) were measured on the 0.1 absorbance range. 
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Table 1 
Carboxyl-terminal sequence analysis of free and lyase-released 
ubiquitin 
Treatment Red cell ubiquitin Lyase ubiquitin 
Carboxypeptidase B Neg. Neg. 
Hydrazinolysis GlY GlY 
Trypsin Gly-Gly Gly-Gly 
Carboxypeptidase treatments were performed on 10 wg 
ubiquitin as in section 2. Hydrazinolysis was performed on 
25-50 ng ubiquitin as described. Abbreviation: Neg., 
Hydrazinolysis showed the presence of a terminal 
glycine in both red-cell and lyase-cleaved ubiquitin, 
while carboxypeptidase B treatment released no 
amino acids. Accordingly, all of the ubiquitin from 
the protein A24 lyase reaction had a C-terminal 
glycine which is resistant to carboxypeptidase B and 
none had an arginine C-terminal (table 1). 
To determine whether the protein A24 lyase 
derived ubiquitin was contaminated with endogenous 
ubiquitin the lyase reaction was carried out both in 
the absence and the presence of exogenous protein 
A24 as substrate. Analysis of trypsin treated flow- 
through fractions from the tandem DEAE-Sephadex 
and phosphocellulose columns showed that the puta- 
tive glycylglycine cleaved from ubiquitin, was not 
found in the absence of substrate (Bg.3). 
4. Discussion 
Previous reports indicated that arginine residue 74 
of the ubiquitin portion of protein A24 was directly 
linked to a glycylglycine ‘bridge’ between the ubi- 
quitin and histone 2A portions [6-81. Arginine was 
H 
Ub: Met---Arg-Gly-N-CH2-C 
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NH 
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1 (LYS 119) 129 
Fig.4. The site of protein A24 lyase cleavage. The lyase 
cleavage site is shown to be the isopeptide linkage between 
the COOH-terminus of ubiquitin and the e-NH, group of 
lysine 119 of histone 2A. 
reported to be the COOH-terminal amino acid of free 
ubiquitin from calf thymus [5,27]. Ubiquitin from 
trout testis was reported to have heterogeneity at 
the COOH-terminus, l/2 of the population terminating 
with arginine and l/2 with glycine [ 161. In the rabbit 
reticulocyte lysate system, ubiquitin (APF-I) conju- 
gation [28,29] has been identified as a necessary 
factor involved in ATP-dependent proteolysis [22,23]. 
The form of ubiquitin active in ATP-dependent 
proteolysis terminates in glycine [30]. This study 
demonstrates that rat erythrocyte ubiquitin con- 
tained a COOH-terminal glycylglycine which confirms 
previous results with human ubiquitin (Wilkinson, 
K. D. and Audhya, T. K., personal communication). 
The reported heterogeneity of the carboxyl-terminus 
of free ubiquitin [5 ,16,27] may possibly have 
resulted from proteolysis during the isolation proce- 
dures [31,32]. 
Here, trypsinization, carboxypeptidase B treat- 
ment, and hydrazinolysis of ubiquitin released from 
purified protein A24 by the lyase reaction indicated 
that it had a carboxyl-terminal glycylglycine. Accord- 
ingly, rat liver nuclear protein A24 lyase cleaved at 
the isopeptide linkage between the carboxyl-group of 
glycine residue 76 of ubiquitin and the e-amino group 
of lysine residue 119 of histone 2A [6-81. Therefore, 
protein A24 lyase is an isopeptidase (fig.4). 
Protein A24 turnover throughout interphase [ 181 
and loss of protein A24 in metaphase chromosomes 
[33] and in nuclei during chicken erythropoiesis [34] 
suggests that the conjugate may be associated with 
potentially active chromatin structures [34,35]. 
Moreover, the ability of protein A24 lyase to release 
ubiquitin with the glycylglycine COOH-terminus as 
shown here implies that lyase-relased ubiquitin may 
be reutilized. 
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